334 related articles for article (PubMed ID: 9366728)
1. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
Kuusisto J; Koivisto K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Kervinen K; Kesäniemi YA; Riekkinen PJ; Laakso M
BMJ; 1997 Oct; 315(7115):1045-9. PubMed ID: 9366728
[TBL] [Abstract][Full Text] [Related]
2. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
Kuusisto J; Koivisto K; Kervinen K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Pyörälä K; Kesäniemi YA; Riekkinen P
BMJ; 1994 Sep; 309(6955):636-8. PubMed ID: 8086986
[TBL] [Abstract][Full Text] [Related]
3. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease.
Hirono N; Mori E; Yasuda M; Imamura T; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Yamashita H
J Neuropsychiatry Clin Neurosci; 1999; 11(1):66-70. PubMed ID: 9990558
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.
van Duijn CM; Havekes LM; Van Broeckhoven C; de Knijff P; Hofman A
BMJ; 1995 Mar; 310(6980):627-31. PubMed ID: 7703749
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.
Tilvis RS; Strandberg TE; Juva K
J Am Geriatr Soc; 1998 Jun; 46(6):712-5. PubMed ID: 9625186
[TBL] [Abstract][Full Text] [Related]
7. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.
Laakso M; Kesäniemi A; Kervinen K; Jauhiainen M; Pyörälä K
BMJ; 1991 Nov; 303(6811):1159-62. PubMed ID: 1747611
[TBL] [Abstract][Full Text] [Related]
8. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.
Notkola IL; Sulkava R; Pekkanen J; Erkinjuntti T; Ehnholm C; Kivinen P; Tuomilehto J; Nissinen A
Neuroepidemiology; 1998; 17(1):14-20. PubMed ID: 9549720
[TBL] [Abstract][Full Text] [Related]
9. Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease.
Moceri VM; Kukull WA; Emanual I; van Belle G; Starr JR; Schellenberg GD; McCormick WC; Bowen JD; Teri L; Larson EB
Epidemiology; 2001 Jul; 12(4):383-9. PubMed ID: 11416775
[TBL] [Abstract][Full Text] [Related]
10. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.
Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Soininen H; Tuomilehto J; Nissinen A
BMJ; 2001 Jun; 322(7300):1447-51. PubMed ID: 11408299
[TBL] [Abstract][Full Text] [Related]
11. Association of metabolic syndrome with Alzheimer disease: a population-based study.
Vanhanen M; Koivisto K; Moilanen L; Helkala EL; Hänninen T; Soininen H; Kervinen K; Kesäniemi YA; Laakso M; Kuusisto J
Neurology; 2006 Sep; 67(5):843-7. PubMed ID: 16966548
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease.
Craig D; Hart DJ; McCool K; McIlroy SP; Passmore AP
J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1327-30. PubMed ID: 15314125
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study.
Koivisto AM; Lempiäinen P; Koivisto K; Helkala EL; Mykkänen L; Kuusisto J; Kervinen K; Kesäniemi YA; Laakso M; Soininen H
Neuroepidemiology; 2000; 19(6):327-32. PubMed ID: 11060507
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E4: phenotype in patients with Alzheimer's disease.
Mahieux F; Couderc R; Moulignier A; Bailleul S; Podrabinek N; Laudet J
Ann Neurol; 1994 Apr; 35(4):506-7. PubMed ID: 8154882
[No Abstract] [Full Text] [Related]
15. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Alzheimer's disease and apolipoprotein E allele frequencies in the Old Order Amish.
Holder J; Warren AC
J Neuropsychiatry Clin Neurosci; 1998; 10(1):100-2. PubMed ID: 9547474
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
Goldknopf IL; Park HR; Sabbagh M
Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
[TBL] [Abstract][Full Text] [Related]
18. Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Ylilauri MP; Voutilainen S; Lönnroos E; Mursu J; Virtanen HE; Koskinen TT; Salonen JT; Tuomainen TP; Virtanen JK
Am J Clin Nutr; 2017 Feb; 105(2):476-484. PubMed ID: 28052883
[TBL] [Abstract][Full Text] [Related]
19. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J
Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727
[TBL] [Abstract][Full Text] [Related]
20. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.
Bennett DA; Schneider JA; Wilson RS; Bienias JL; Berry-Kravis E; Arnold SE
J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1194-9. PubMed ID: 16107349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
